The advancement of drug delivery devices is critical for the individualization patient treatment and improvement healthcare. Here, we introduce 3DMNMEMS, a novel device that combines 3D printing, microneedles (MNs) Microelectromechanical Systems (MEMS), allowing versatile controllable by user transdermal delivery. Hollow MNs were designed printed using Stereolithography, followed integrating in...

Hepatocellular carcinoma (HCC) is a major health problem. It is currently the third cause of cancer-related death, it is highly prevalent in the Asia-Pacific region and Africa, and is increasing in Western countries. The natural history of HCC is very heterogeneous and prediction of survival in individual patients is not satisfactory because of the wide spectrum of the disease. During the past ...

Management of hepatocellular carcinoma (HCC) can be maximized with the utilization of multiple treatment modalities including transplant, surgical resection and locoregional therapies including ablative therapies and transarterial embolotherapies. Although transplant and surgical resection offer the best clinical outcomes, a limited number of patients are amenable to these surgical treatment op...

Bevacizumab (BV) is a humanized monoclonal antibody targeting vascular endothelial growth factor and it is the first molecular-targeted agent to be used for the treatment of ovarian cancer (OC). Randomized Phase III trials evaluated the combination of BV plus standard chemotherapy for first-line treatment of advanced OC and for platinum-sensitive and platinum-resistant recurrent OC. These trial...

Platinum-based chemotherapy is commonly used for the treatment of locally advanced and metastatic bladder cancer. However, there are currently no methods to predict chemotherapy response in this disease setting. A better understanding of the biology of bladder cancer has led to developments of molecular biomarkers that may help guide clinical decision making. These biomarkers, while promising, ...

a headspace-solid phase microextraction (hs-spme) and gas chromatography-mass spectrometry (gc-ms) method has been developed for the simultaneously determination of 20 disinfection by-products (dbps) in water samples from reverse osmosis (ro) membranes. selected compounds belong to different families including: trihalomethanes (thms), halogenated acetonitriles (hans), halogenated nitromethanes ...

Acute myeloid leukemia (AML) in older patients presents a notable therapeutic challenge to the clinical hematologist. The clinical biology of AML among patients is highly heterogeneous. Interpatient variations are relevant for prognosis and treatment choice. Outcome of treatment for patients of advanced age is often compromised by comorbid conditions and an enhanced susceptibility to toxicities...

Abstract Ovarian malignancy is the seventh most frequently diagnosed cancer among women. The common type epithelial ovarian cancer. Several subtypes with distinct biological and molecular properties exist, there inconsistency in availability of access to different modalities treatment. standard first-line management combining surgery platinum-based chemotherapy. Most them are at an advanced sta...

Preoperative radiotherapy or chemoradiotherapy has become a standard procedure for treatment of patients with locally advanced colorectal cancer (CRC). However, patients' responses to treatment are different and personalized. MicroRNAs (miRNAs) are promising biomarkers for predicting personalized responses. In this study, we collected 30 publicly reported miRNAs associated with chemoradiotherap...

The prognosis of non-small cell lung cancer (NSCLC) patients who failed two or more treatment regimens remains very poor. We conducted a phase II study to explore the feasibility of personalized peptide vaccination (PPV), in which peptides are selected and administered based on the pre-existing host immunity before vaccination, as a third or more line treatment in advanced NSCLC patients who fa...